|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2187741 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08795303.0 |
| Date of filing the European patent application | 2008-08-14 | |
| (97) | Date of publication of the European application | 2010-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-14 |
| (46) | Date of publication of the claims translation | 2012-06-25 |
| (86) | Number | PCT/US2008/009703 |
| Date | 2008-08-14 |
| (87) | Number | WO 2009/023232 |
| Date | 2009-02-19 |
| (30) | Number | Date | Country code |
| 955939 P | 2007-08-15 | US |
| (72) |
WALLING, John, US
PARENT, Stephan, D., US
JONAITIS, David, T., US
KRAL, Robert, M., US
|
| (73) |
Reata Pharmaceuticals Holdings, LLC,
5320 Legacy Drive, Plano, TX 75024,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujos CDDO metilo esterio formos |
| NOVEL FORMS OF CDDO METHYL ESTER |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 18 | 347.00 EUR |
| 2026-08-14 |